Making
Hope Real.
Making
Hope Real.
The vision of the Snowdome Foundation is to ensure every Australian blood cancer
patient has the best opportunity for a cure, and this starts with a correct diagnosis.
We collaborate with world-leading Australian and international blood cancer researchers
to accelerate new therapies and bring next-generation treatments to patients, faster.
We are the leading not-for-profit organisation focused exclusively on raising funds to
support translational research and clinical trials that will accelerate new treatments
(and cures) to help Australian blood cancer patients live longer, better lives.
Over $53 million has been committed to blood cancer research since 2010.
67 research projects funded enabling over 98 research positions.
Over 6,200 genomic tests completed at the Wilson Centre for Blood Cancer Genomics.
Enabled 1,817 patients to participate in clinical trials supported by Snowdome.
Latest News
‘In Her Words’ screening at the Wilson Centre for Blood Cancer Genomics
In recognition of the incredible generosity of the Wilson family and the impact of the Wilson Centre for Blood Cancer Genomics, the story of their inspiration is captured in a heart-warming film, ‘In Her Words’. The film is screening on the digital supporter wall at the Peter MacCallum Cancer Centre. Snowdome founder and director, Grant … Continued
Read more
Cilta-cel approved for public funding
Multiple Myeloma The Snowdome Foundation is delighted to learn that ciltacabtagene autoleucel (cilta-cel), a revolutionary Chimeric Antigen Receptor (CAR) T-cell treatment, will now be a reality for patients with refractory or relapsed multiple myeloma who have had four prior lines of treatment. The Medical Services Advisory Committee (MSAC) reviews new medical services to advise the … Continued
Read more
Global partnership to fund groundbreaking research in treatment of multiple myeloma
Multiple Myeloma Groundbreaking research aimed at translating novel Chimeric Antigen Receptor (CAR) T-cell therapies into improved treatment for multiple myeloma is the latest Australian research to be funded through the prestigious Translational Research Program (TRP). Now into its sixth year, this international collaboration between The Leukemia & Lymphoma Society (LLS) and the Snowdome Foundation has … Continued
Read moreSign up for our newsletter
Sign up to our quarterly newsletter to read
all the latest news from Snowdome.
